
Gloucester Pharmaceuticals
Gloucester Pharmaceuticals acquires clinical-stage oncology drug candidates and advances them through approvals and commercialization.
Date | Investors | Amount | Round |
---|---|---|---|
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor investor investor investor investor | €0.0 | round | |
$640m Valuation: $640m | Acquisition | ||
Total Funding | 000k |





Related Content
Gloucester Pharmacy is a healthcare provider that goes beyond the traditional pharmacy model by offering personalized care to its clients. Located in the Middle Peninsula, the pharmacy serves a diverse range of customers, including individuals seeking prescription refills and those in need of over-the-counter remedies. The business operates in the healthcare market, focusing on both prescription and non-prescription products. Its business model revolves around providing high-quality, personalized healthcare services, which include filling prescriptions and offering a complete line of non-prescription remedies. The pharmacy generates revenue through the sale of these products and services, aiming to meet the unique healthcare needs of its community.
Keywords: personalized care, prescription refills, non-prescription remedies, healthcare, Middle Peninsula, pharmacy, customer-focused, high-quality service, healthcare provider, community-focused.